Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Past 24 hours
Any time
Past hour
Past 7 days
Past 30 days
Best match
Most recent
biopharma-reporter
1h
Alto Neuroscience’s depression drug trial fails at phase 2
The negative trial results have tanked the California-based biotech’s market value, with a 70% reduction in share price over ...
biopharma-reporter
5h
The FDA has approved Pfizer’s RSV vaccine Abrysvo for adults aged 18 to 59
The US pharma giant Pfizer recently announced that its respiratory syncytial virus (RSV) vaccine Abrysvo has received FDA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
Workers reject new contract
Settles civil lawsuit
Accused of plagiarism
Oldest person in US dies
Grizzly bear fatally struck
Courthouse attack charges
Court orders new sentence
Timberlake postpones shows
'Tarzan' star Ron Ely dies
DOJ warns Musk's PAC?
Suffers 'debilitating' stroke
Joins Republican Party
$3.9B storm relief proposal
Seeks WI ballot exit
Carbon removal firms report
Pneumococcal vax advice
New lead dust standards
Existing home sales fall
911 calls from rally released
Wins EU antitrust case
Settles hazardous waste suit
NK troops in RU confirmed
Georgia repels cyberattack
DNC office shootings arrest
G7 Ukraine loan advances
Kentucky lawmaker dies
Israel strikes Lebanese city
FDA recalls antidepressant
Bird flu infects 4 in WA
Yelp disables reviews
Biden says lock up Trump
Feedback